Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 03:49:24 +0200Tue, 25 Jun 2024 16:51:00 +0200Human medicines European public assessment report (EPAR): Bimzelx, bimekizumab, Date of authorisation: 20/08/2021, Revision: 7, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/bimzelxHuman medicines European public assessment report (EPAR): Bimzelx, bimekizumab, Date of authorisation: 20/08/2021, Revision: 7, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/bimzelxTue, 25 Jun 2024 16:51:00 +0200Human medicineBimzelx : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5316-en_1.pdfBimzelx : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5316-en_1.pdfTue, 25 Jun 2024 13:55:00 +0200Human medicine